MAOA and breast cancer: In an experimental study [98], the action of the monoamine oxidase-A (MAO-A) inhibitor clorgyline was evaluated in the epithelial ER-positive MCF-7 and the post-EMT (mesenchymal) ER-negative MDA-MB-231 human breast cancer cell lines.